Aberdeen Group
CLB icon

Aberdeen Group’s Core Laboratories CLB Stock Holding History

Aberdeen Group’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-360,374
Closed -$13.6M – 918
2019
Q4 		$13.6M Buy
360,374
+5,580
+2% +$251K 0.03% 399
2019
Q3 		$16.5M Buy
354,794
+1,808
+0.5% +$84.1K 0.04% 355
2019
Q2 		$18.5M Buy
352,986
+339,711
+2,559% +$19.9M 0.04% 377
2019
Q1 		$915K Hold
13,275
– – ﹤0.01% 817
2018
Q4 		$790K Buy
13,275
+3,775
+40% +$326K ﹤0.01% 782
2018
Q3 		$1.1M Buy
9,500
+2,025
+27% +$228K ﹤0.01% 791
2018
Q2 		$943K Sell
7,475
-76
-1% -$9.25K ﹤0.01% 802
2018
Q1 		$817K Hold
7,551
– – ﹤0.01% 749
2017
Q4 		$827K Buy
7,551
+1,100
+17% +$110K ﹤0.01% 745
2017
Q3 		$637K Buy
+6,451
New +$625K ﹤0.01% 744

Other funds holding CLB

VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Aberdeen Group's CLB Position: Q1 2020 in Review

Aberdeen Group sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 360,374 shares — an estimated $13.6M sold.

Aberdeen Group first reported a position in CLB in Q3 2017 and held it in 10 quarters. The position peaked at $18.5M in Q2 2019. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.

  • Aberdeen Group reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
  • Aberdeen Group sold 360,374 Core Laboratories shares in Q1 2020, an estimated $13.6M.
  • Aberdeen Group first reported a position in Core Laboratories in Q3 2017 and held it in 10 quarters.
  • Aberdeen Group's Core Laboratories position peaked at $18.5M in Q2 2019.
  • 207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.

Based on Aberdeen Group's 13F filing for Q1 2020, filed 13 May 2020.